Antoinette Moran

Active

Wanek Family Project for Type 1 Diabetes/Multicenter Clinical Trial Planning

Moran, A. (PI), Beasley, S. (Other Role) & Pappenfus, B. M. (Other Role)

CITY OF HOPE

6/1/24 → 11/30/24

Project: Research project

Tracking disease progression in early state T1D using an automated version of the oral minimal model

Moran, A. (PI)

CARDIFF UNIVERSITY, BREAKTHROUGH T1D

8/1/23 → 7/31/26

Project: Research project

EnVision CF III: Emerging Leaders in CF Endocrinology

Moran, A. (PI)

CYSTIC FIBROSIS FOUNDATION

4/1/23 → 3/31/26

Project: Research project

Hybrid Closed Loop Therapy for Beta cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX)

Moran, A. (PI)

BREAKTHROUGH T1D

4/1/23 → 3/31/26

Project: Research project

Single Arm, Open-label Study to Assess the Safety and Pharmacokinetics of a 14-day Regimen ofTeplizumab in Pediatric Stage 2 Type 1 Diabetes (Participants <8 Years of Age With at Least TwoAutoantibodies and Dysglycemia)

Moran, A. (PI)

PROVENTION BIO, INC.

3/27/23 → 3/31/28

Project: Research project

Diabetes in African Youth: Improving Glucose Time-In-Range

Moran, A. (PI) & Sunni, M. (CoI)

NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

4/1/22 → 3/31/27

Project: Research project

Protocol ITN095AI DESIGNATE - A T cell phenotype signature driven dose finding study with siplizumab in type 1 diabetes mellitus

Moran, A. (PI)

BENAROYA RESEARCH INST AT VIRGINIA MASON, NIH Nat'l Inst of Allergy & Infect Dis

2/1/22 → 1/31/25

Project: Research project

University of Minnesota Clinical Center for the Study of Acute Pancreatitis and Diabetes

Bellin, M. D. (PI), Fife, B. T. (CoI), Freeman, M. L. (CoI), Harindhanavudhi, T. (CoI), Moran, A. (CoI), Spilseth, B. D. (CoI) & Trikudanathan, G. V. (Co-Principal Investigator)

NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

9/17/20 → 7/31/25

Project: Research project

Pre-faculty Research Training in Pediatric Endocrinology

Bellin, M. D. (PI), Nathan, B. M. (CoI) & Moran, A. (Prior Principal Investigator)

NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

7/1/20 → 6/30/25

Project: Research project

TYPE 1 DIABETES EXTENSION STUDY (TIDES)

Moran, A. (PI)

BENAROYA RESEARCH INST AT VIRGINIA MASON, NIH Nat'l Inst of Allergy & Infect Dis

2/1/17 → 1/31/25

Project: Research project

Finished

Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX)

Moran, A. (PI)

BREAKTHROUGH T1D

10/1/22 → 3/31/24

Project: Research project

Efficacy and safety of GLP-1 agonist therapy in overweight and obese subjects with cystic fibrosis-related diabetes: a pilot study

Moheet, A. (PI), Moran, A. (CoI) & Wang, Q. (CoI)

CYSTIC FIBROSIS FOUNDATION

6/1/22 → 5/31/24

Project: Research project

A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety ofTeplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children andAdolescents with Recent-Onset Type 1 Diabetes Mellitus

Moran, A. (PI)

PROVENTION BIO, INC.

8/23/21 → 1/12/22

Project: Research project

Protocol Chair for "A randomized, double masked, placebo-controlled, dose escalation study to evaluatethe safety and efficacy of immunotherapy with multiple peptides (MultiPepT1De) in pediatric participantswith new-onset Type 1 diabetes (iMMPepBeta)

Moran, A. (PI)

JAEB CENTER FOR HEALTH RESEARCH

8/1/21 → 3/14/23

Project: Research project

Data Coordinating Center for Type I Diabetes TrialNet

Moran, A. (PI)

UNIVERSITY OF SOUTH FLORIDA, NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

2/1/20 → 6/30/24

Project: Research project

Factors Influencing HbA1c Variability in Children and Youth in Uganda

Moran, A. (PI)

ABBOTT LABORATORIES

1/1/20 → 3/31/24

Project: Research project

EnVision Chair

Moran, A. (PI) & Moheet, A. (Other Role)

CYSTIC FIBROSIS FOUNDATION

10/1/19 → 3/31/23

Project: Research project

Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type I Diabetes: A Proof-of-Concept Study

Moran, A. (PI) & McVean, J. J. (CoI)

BREAKTHROUGH T1D

9/1/19 → 12/31/23

Project: Research project

A Phase 3, Randomized, Double-Blind, Multinational, Placebo-Controlled Study toEvaluate Efficacy and Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding,anti-CD3 Monoclonal Antibody, in Children and Adolescents with Newly Diagnosed Type1 Dia

Moran, A. (PI)

PROVENTION BIO, INC.

6/1/19 → 5/31/24

Project: Research project

A prospective, multi-center, Phase 1b/2a study to assess the safety and tolerability of different doses ofAG019 administered alone or in association with teplizumab in subjects with clinical recent-onset Type 1Diabetes Mellitus (T1D).

Moran, A. (PI)

INTREXON CORPORATION

7/1/18 → 7/31/22

Project: Research project

Immune Tolerance Network

Moran, A. (PI)

BENAROYA RESEARCH INST AT VIRGINIA MASON, NATIONAL INSTITUTES OF HEALTH (NIH)

12/1/16 → 1/31/18

Project: Research project

EnVision CF: Emerging Leaders in CF Endocrinology

Moran, A. (PI)

CYSTIC FIBROSIS FOUNDATION

9/1/16 → 8/31/19

Project: Research project

A Prospective Randomized Placebo-Controlled Double Blind

Moran, A. (PI)

CALADRIUS BIOSCIENCES, INC

6/1/16 → 3/30/20

Project: Research project

Impact of Insulin Therapy on Protein Turnover in Non-Dia

Moran, A. (PI) & Zhang, L. (CoI)

CYSTIC FIBROSIS FOUNDATION

4/1/16 → 3/31/22

Project: Research project

Allan Drash Clinical Fellowship 2015 - Subramonian

Moran, A. (PI)

INT'L SOC FOR PED & ADOLESCENT DIABETES

8/1/15 → 10/31/15

Project: Research project

Impact of Insulin Therapy on Protein Turnover in Pre-Dia

Moran, A. (PI)

NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

8/1/15 → 6/1/22

Project: Research project

EXTEND - Preserving Beta-Cell Function with Tocilizumab

Moran, A. (PI)

BENAROYA RESEARCH INST AT VIRGINIA MASON, NIH Nat'l Inst of Allergy & Infect Dis

9/1/14 → 1/31/22

Project: Research project

Type 1 Diabetes-A Proposal for Prevention & Intervention

Moran, A. (PI) & Nathan, B. M. (CoI)

NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

8/1/14 → 4/30/20

Project: Research project

A Two-part Multicenter Prospective Longitudinal Study of

Moran, A. (PI)

CYSTIC FIBROSIS FOUNDATION

7/1/14 → 6/30/19

Project: Research project

Pre-Faculty Research Training in Pediatric Endocrinology

Moran, A. (PI)

NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

7/1/14 → 6/30/20

Project: Research project

Inflammatory Lipid Biomarkers for Early Detection of Bet

Moran, A. (PI)

MICHIGAN STATE UNIVERSITY, BREAKTHROUGH T1D

6/1/14 → 5/31/16

Project: Research project

Allan Drash Clinical Fellowship 2013

Moran, A. (PI)

INT'L SOC FOR PED & ADOLESCENT DIABETES

5/1/14 → 10/31/14

Project: Research project

A Phase 1 Study to Evaluate the Safety, Tolerability

Moran, A. (PI), Bellin, M. D. (CoI), Nathan, B. M. (CoI) & Sunni, M. (CoI)

PFIZER, INC.

4/1/14 → 9/30/18

Project: Research project

Preserving Beta Cell Function with Tocilizumab in New On

Moran, A. (PI)

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, NIH Nat'l Inst of Allergy & Infect Dis

10/1/13 → 4/30/14

Project: Research project

Genetic Modifiers of Cystic Fibrosis Related Diabetes

Moran, A. (PI)

JOHNS HOPKINS UNIVERSITY, NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

2/25/13 → 12/31/13

Project: Research project

A randomized, double-blind, multiple dose, placebo-contr

Moran, A. (PI)

NOVARTIS PHARMACEUTICALS CORPORATION

8/17/12 → 3/1/16

Project: Research project

Early Pathogenesis of Cystic Fibrosis Related Diabetes

Moran, A. (PI) & Laguna, T. (CoI)

THE UNIVERSITY OF IOWA, NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

8/15/12 → 6/30/17

Project: Research project

Practical Two-step Screening for CFRD and Prediabetes

Moran, A. (PI)

EMORY UNIVERSITY, CYSTIC FIBROSIS FOUNDATION

7/1/12 → 6/30/15

Project: Research project

Pfizer Type 1 Diabetes Drug Development-A Preliminary La

Moran, A. (PI)

PFIZER, INC.

8/1/11 → 9/25/14

Project: Research project

ITN045AI: Inducing Remission in New Onset T1DM With Alef

Moran, A. (PI)

IMMUNE TOLERANCE NETWORK, NIH Nat'l Inst of Allergy & Infect Dis

4/1/11 → 12/31/11

Project: Research project

Bedside to Bench and Back Again: Training Pediatricians in Translational Research

Neglia, J. P. (PI), Georgieff, M. K. (Other Role), Moran, A. (Other Role) & Schleiss, M. R. (Other Role)

NIH NAT'L INST OF CHILD HEALTH/HUMAN DEV

12/30/10 → 5/31/16

Project: Research project

T1D Exchange

Nathan, B. M. (PI), Moran, A. (CoI) & Moran, A. (Prior Principal Investigator)

JAEB CENTER FOR HEALTH RESEARCH, LEONA M & HARRY B HELMSLEY CHAR. TRUST

12/6/10 → 3/31/19

Project: Research project

A Double-blind, Randomized, Placebo Controlled Intervent

Moran, A. (PI)

MERCK AND CO INC

10/6/10 → 7/31/12

Project: Research project

DEFEND 2: Durable-Response Therapy Evaluation for Early-

Moran, A. (PI)

Tolerx, Inc.

8/1/10 → 7/31/13

Project: Research project

TRX4 Therapeutic Evaluation of Different Multi-Dose Regi

Moran, A. (PI)

Tolerx, Inc.

2/17/10 → 2/29/16

Project: Research project

Type 1 Diabetes-A Proposal for Prevention & Intervention

Moran, A. (PI), Nathan, B. M. (CoI), Peterson, K. A. (CoI) & Wagner, J. E. (CoI)

NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

9/30/09 → 5/31/14

Project: Research project

Prospective Study of Outcomes Following Pancreatectomy a

Sutherland, D. (PI), Beilman, G. J. (CoI), Bellin, M. D. (CoI), Moran, A. (CoI) & Radosevich, D. M. (CoI)

THE NATIONAL PANCREAS FOUNDATION

6/1/09 → 3/31/11

Project: Research project

A Phase II, multicenter, randomized, double-blind, place

Moran, A. (PI), Nathan, B. M. (CoI) & Wagner, J. E. (CoI)

Osiris Therapeutics, Inc.

9/19/08 → 6/30/12

Project: Research project

Type 1 Diabetes TrialNet Clincal Affiliate

Moran, A. (PI)

UNIVERSITY OF SOUTH FLORIDA, NATIONAL INSTITUTES OF HEALTH (NIH)

9/1/08 → 6/30/24

Project: Research project

Type 1 Diabetes-A Proposal for Prevention & Intervention

Moran, A. (PI), Nathan, B. M. (CoI) & Wagner, J. E. (CoI)

UNIVERSITY OF SOUTH FLORIDA, NIH NATL INST OF DIABETES/DIG/KIDNEY DIS

7/1/08 → 9/29/09

Project: Research project

Antoinette Moran

Projects

Search results